Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 1033 - 1040 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC4955 | NXY-059 |
|
Free radical trapping agent. Reduces infarct size and preserves brain function in several animal models of acute ischemic stroke. Neuroprotectant.
|
|
| BCC4961 | Suplatast Tosylate |
|
Th2 cytokine inhibitor that attenuates IL-2, IL-5 and IL-13 production and has no effect on IFN-<span class='symbol'>γ</span> production. Acts as an immunoregulator that suppresses IgE production, eosinophil infiltration and histamine release. Exhibits antiasthmatic, anti-inflammatory and antifibrotic activity <em>in vivo</em> and is orally active.
|
|
| BCC4962 | Alfacalcidol |
|
Metabolite and prodrug of vitamin D<sub>3</sub>. Improves mechanical bone strength and bone mass; suppresses osteoclastic bone resorption <em>in vivo</em>.
|
|
| BCC4963 | Alprostadil |
|
Prostaglandin with some selectivity for EP3 and EP4 receptors (Ki values are 1.1, 2.1, 36, 10 and 33 nM for mouse EP3, EP4, EP1, EP2 and IP receptors respectively). Inhibits platelet aggregation and is a vasodilator in vivo.
|
|
| BCC4970 | Nanchangmycin |
|
Antiviral. Inhibits Zika virus entry in a range of cell types including primary placental fibroblast cells, HUVECs and UtMECs (IC50 values are 0.1, 0.4 and 0.97 μM in U2OS, HBMECs and Jeg-3 cells respectively). Also inhibits cellular uptake of West Nile, dengue, sindbis and chikungunya viruses.
|
|
| BCC4972 | SB408124 |
|
Selective non-peptide orexin OX1 receptor antagonist (Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). Blocks orexin-A induced grooming following oral administration in vivo.
|
|
| BCC4973 | Ticlopidine HCl |
|
Selective P2Y12 receptor antagonist. Inhibits ADP-induced platelet aggregation and displays antithrombotic activity following oral administration in vivo.
|
|
| BCC4974 | GW791343 HCl |
|
P2X<sub>7</sub> allosteric modulator. Exhibits species-specific activity; acts as a negative allosteric modulator of human P2X<sub>7</sub> (pIC<sub>50</sub> = 6.9 - 7.2) and a positive allosteric modulator of rat P2X<sub>7</sub>.
|
|